Alison Silvis Rustagi1, Sarah Gimbel, Ruth Nduati, Maria de Fatima Cuembelo, Judith N Wasserheit, Carey Farquhar, Stephen Gloyd, Kenneth Sherr. 1. *Department of Global Health, University of Washington, Seattle, WA;†Department of Family and Child Nursing, School of Nursing, University of Washington, Seattle, WA;‡Health Alliance International, Seattle, WA;§Department of Paediatrics, University of Nairobi, Nairobi, Kenya;‖Network of AIDS Researchers of Eastern and Southern Africa (NARESA), Nairobi, Kenya;¶Department of Community Health, School of Medicine, University of Eduardo Mondlane, Maputo, Mozambique;Departments of #Medicine; and**Epidemiology, University of Washington, Seattle, WA.
Abstract
BACKGROUND: Efficacious interventions to prevent mother-to-child HIV transmission (PMTCT) have not translated well into effective programs. Previous studies of systems engineering applications to PMTCT lacked comparison groups or randomization. METHODS:Thirty-six health facilities in Côte d'Ivoire, Kenya, and Mozambique were randomized to usual care or a systems engineering intervention, stratified by country and volume. The intervention guided facility staff to iteratively identify and then rectify barriers to PMTCT implementation. Registry data quantified coverage of HIV testing during first antenatal care visit, antiretrovirals (ARVs) for HIV-positive pregnant women, and screening HIV-exposed infants (HEI) for HIV by 6-8 weeks. We compared the change between baseline (January 2013-January 2014) and postintervention (January 2015-March 2015) periods using t-tests. All analyses were intent-to-treat. RESULTS:ARV coverage increased 3-fold [+13.3% points (95% CI: 0.5 to 26.0) in intervention vs. +4.1 (-12.6 to 20.7) in control facilities] and HEI screening increased 17-fold [+11.6 (-2.6 to 25.7) in intervention vs. +0.7 (-12.9 to 14.4) in control facilities]. In prespecified subgroup analyses, ARV coverage increased significantly in Kenya [+20.9 (-3.1 to 44.9) in intervention vs. -21.2 (-52.7 to 10.4) in controls; P = 0.02]. HEI screening increased significantly in Mozambique [+23.1 (10.3 to 35.8) in intervention vs. +3.7 (-13.1 to 20.6) in controls; P = 0.04]. HIV testing did not differ significantly between arms. CONCLUSIONS: In this first randomized trial of systems engineering to improve PMTCT, we saw substantially larger improvements in ARV coverage and HEI screening in intervention facilities compared with controls, which were significant in prespecified subgroups. Systems engineering could strengthen PMTCT service delivery and protect infants from HIV.
RCT Entities:
BACKGROUND: Efficacious interventions to prevent mother-to-child HIV transmission (PMTCT) have not translated well into effective programs. Previous studies of systems engineering applications to PMTCT lacked comparison groups or randomization. METHODS: Thirty-six health facilities in Côte d'Ivoire, Kenya, and Mozambique were randomized to usual care or a systems engineering intervention, stratified by country and volume. The intervention guided facility staff to iteratively identify and then rectify barriers to PMTCT implementation. Registry data quantified coverage of HIV testing during first antenatal care visit, antiretrovirals (ARVs) for HIV-positive pregnant women, and screening HIV-exposed infants (HEI) for HIV by 6-8 weeks. We compared the change between baseline (January 2013-January 2014) and postintervention (January 2015-March 2015) periods using t-tests. All analyses were intent-to-treat. RESULTS: ARV coverage increased 3-fold [+13.3% points (95% CI: 0.5 to 26.0) in intervention vs. +4.1 (-12.6 to 20.7) in control facilities] and HEI screening increased 17-fold [+11.6 (-2.6 to 25.7) in intervention vs. +0.7 (-12.9 to 14.4) in control facilities]. In prespecified subgroup analyses, ARV coverage increased significantly in Kenya [+20.9 (-3.1 to 44.9) in intervention vs. -21.2 (-52.7 to 10.4) in controls; P = 0.02]. HEI screening increased significantly in Mozambique [+23.1 (10.3 to 35.8) in intervention vs. +3.7 (-13.1 to 20.6) in controls; P = 0.04]. HIV testing did not differ significantly between arms. CONCLUSIONS: In this first randomized trial of systems engineering to improve PMTCT, we saw substantially larger improvements in ARV coverage and HEI screening in intervention facilities compared with controls, which were significant in prespecified subgroups. Systems engineering could strengthen PMTCT service delivery and protect infants from HIV.
Authors: Claire L Townsend; Mario Cortina-Borja; Catherine S Peckham; Annemiek de Ruiter; Hermione Lyall; Pat A Tookey Journal: AIDS Date: 2008-05-11 Impact factor: 4.177
Authors: Lynn T Matthews; Heather B Ribaudo; Angela Kaida; Kara Bennett; Nicholas Musinguzi; Mark J Siedner; Jerome Kabakyenga; Peter W Hunt; Jeffrey N Martin; Yap Boum; Jessica E Haberer; David R Bangsberg Journal: J Acquir Immune Defic Syndr Date: 2016-04-01 Impact factor: 3.731
Authors: Laura J Damschroder; David C Aron; Rosalind E Keith; Susan R Kirsh; Jeffery A Alexander; Julie C Lowery Journal: Implement Sci Date: 2009-08-07 Impact factor: 7.327
Authors: Anisa Ghadrshenas; Yanis Ben Amor; Joy Chang; Helen Dale; Gayle Sherman; Lara Vojnov; Paul Young; Ram Yogev Journal: AIDS Date: 2013-11 Impact factor: 4.177
Authors: Susie Huntington; Claire Thorne; Marie-Louise Newell; Jane Anderson; Graham P Taylor; Deenan Pillay; Teresa Hill; Pat A Tookey; Caroline Sabin Journal: AIDS Date: 2015-11 Impact factor: 4.177
Authors: Anjuli D Wagner; Sarah Gimbel; Kristjana H Ásbjörnsdóttir; Peter Cherutich; Joana Coutinho; Jonny Crocker; Emilia Cruz; Fatima Cuembelo; Vasco Cumbe; McKenna Eastment; Jennifer Einberg; Florencia Floriano; Douglas Gaitho; Brandon L Guthrie; Grace John-Stewart; Alex H Kral; Barrot H Lambdin; Shan Liu; Martin Maina; Nelia Manaca; Mika Matsuzaki; Loris Mattox; Nancy Mburu; R Scott McClelland; Mark A Micek; Ana Olga Mocumbi; Alberto Muanido; Ruth Nduati; Irene N Njuguna; Geoffrey Oluoch; Laura B Oyiengo; Keshet Ronen; Caroline Soi; Bradley H Wagenaar; George Wanje; Lynn D Wenger; Kenneth Sherr Journal: J Acquir Immune Defic Syndr Date: 2019-12 Impact factor: 3.731
Authors: Kathleen Miller; Winnie Muyindike; Lynn T Matthews; Michael Kanyesigye; Mark J Siedner Journal: AIDS Patient Care STDS Date: 2017-06-26 Impact factor: 5.078
Authors: McKenna C Eastment; George Wanje; Barbra A Richardson; Emily Mwaringa; Kenneth Sherr; Ruanne V Barnabas; Martha Perla; Kishorchandra Mandaliya; Walter Jaoko; R Scott McClelland Journal: AIDS Date: 2022-02-01 Impact factor: 4.177
Authors: Bradley H Wagenaar; Sarah Gimbel; Roxanne Hoek; James Pfeiffer; Cathy Michel; Fatima Cuembelo; Titos Quembo; Pires Afonso; Stephen Gloyd; Barrot H Lambdin; Mark A Micek; Victoria Porthé; Kenneth Sherr Journal: Glob Health Action Date: 2016-08-30 Impact factor: 2.640
Authors: Elizabeth Hamilton; Bernard Bossiky; John Ditekemena; Godfrey Esiru; Franck Fwamba; Ameena E Goga; Mary Pat Kieffer; Landry D Tsague; Roland van de Ven; Rose Wafula; Laura Guay Journal: J Acquir Immune Defic Syndr Date: 2017-05-01 Impact factor: 3.731